<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen XY</submitter><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>30368-75</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3436288</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>287(36)</volume><pubmed_abstract>Brain-selective kinase 2 (BRSK2) has been shown to play an essential role in neuronal polarization. In the present study, we show that BRSK2 is also abundantly expressed in pancreatic islets and MIN6 β-cell line. Yeast two-hybrid screening, GST fusion protein pull-down, and co-immunoprecipitation assays reveal that BRSK2 interacts with CDK-related protein kinase PCTAIRE1, a kinase involved in neurite outgrowth and neurotransmitter release. In MIN6 cells, BRSK2 co-localizes with PCTAIRE1 in the cytoplasm and phosphorylates one of its serine residues, Ser-12. Phosphorylation of PCTAIRE1 by BRSK2 reduces glucose-stimulated insulin secretion (GSIS) in MIN6 cells. Conversely, knockdown of BRSK2 by siRNA increases serum insulin levels in mice. Our results reveal a novel function of BRSK2 in the </pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>Brain-selective kinase 2 (BRSK2) phosphorylation on PCTAIRE1 negatively regulates glucose-stimulated insulin secretion in pancreatic β-cells.</pubmed_title><pmcid>PMC3436288</pmcid><funding_grant_id>R01 DK083850</funding_grant_id><funding_grant_id>R01 DK054254</funding_grant_id><funding_grant_id>R01DK054254</funding_grant_id><funding_grant_id>CA124982</funding_grant_id><funding_grant_id>R01 CA124982</funding_grant_id><funding_grant_id>P30 DK020572</funding_grant_id><funding_grant_id>R01DK083850</funding_grant_id><funding_grant_id>R01 HL112248</funding_grant_id><pubmed_authors>Liu JO</pubmed_authors><pubmed_authors>Yu L</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Chen XY</pubmed_authors><pubmed_authors>Wang YF</pubmed_authors><pubmed_authors>Saiyin H</pubmed_authors><pubmed_authors>Gu XT</pubmed_authors><pubmed_authors>Zhang YJ</pubmed_authors><pubmed_authors>Wan B</pubmed_authors><pubmed_authors>Wang YL</pubmed_authors><pubmed_authors>Gao R</pubmed_authors><pubmed_authors>Ding HF</pubmed_authors><pubmed_authors>Dong WP</pubmed_authors><pubmed_authors>Najjar SM</pubmed_authors><pubmed_authors>Zhang CY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Brain-selective kinase 2 (BRSK2) phosphorylation on PCTAIRE1 negatively regulates glucose-stimulated insulin secretion in pancreatic β-cells.</name><description>Brain-selective kinase 2 (BRSK2) has been shown to play an essential role in neuronal polarization. In the present study, we show that BRSK2 is also abundantly expressed in pancreatic islets and MIN6 β-cell line. Yeast two-hybrid screening, GST fusion protein pull-down, and co-immunoprecipitation assays reveal that BRSK2 interacts with CDK-related protein kinase PCTAIRE1, a kinase involved in neurite outgrowth and neurotransmitter release. In MIN6 cells, BRSK2 co-localizes with PCTAIRE1 in the cytoplasm and phosphorylates one of its serine residues, Ser-12. Phosphorylation of PCTAIRE1 by BRSK2 reduces glucose-stimulated insulin secretion (GSIS) in MIN6 cells. Conversely, knockdown of BRSK2 by siRNA increases serum insulin levels in mice. Our results reveal a novel function of BRSK2 in the </description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Aug</publication><modification>2025-04-18T18:26:38.411Z</modification><creation>2019-03-27T00:57:41Z</creation></dates><accession>S-EPMC3436288</accession><cross_references><pubmed>22798068</pubmed><doi>10.1074/jbc.m112.375618</doi><doi>10.1074/jbc.M112.375618</doi></cross_references></HashMap>